Literature DB >> 412213

Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.

H Y Meltzer, R G Fessler, V S Fang.   

Abstract

Perlapine is a dibenzohetereopine compound chemically related to clothiapine, loxapine, and clozapine. Although the latter three compounds are antipsychotic, perlapine has not been reported to be antipsychotic. Nevertheless, all four drugs increase rat plasma prolactin levels. The order of potency is loxapine, perlapine, clothiapine, and clozapine. These results suggest that either perlapine should be reexamined for antipsychotic properties or there are hitherto unsuspected discrepancies between the dopamine receptors relevant to antipsychotic activity in man and those that regulate prolactin secretion in the rat.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412213     DOI: 10.1007/bf00426777

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Clozapine increases rat serum prolactin levels.

Authors:  H Y Meltzer; S Daniels; V S Fang
Journal:  Life Sci       Date:  1975-08-01       Impact factor: 5.037

2.  On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.

Authors:  P C Waldmeier; L Maître
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

3.  Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines: relationship to drug induced Parkinsonism.

Authors:  R J Miller; C R Hiley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Effects of serotonin precursors and melatonin on serum prolactin release in rats.

Authors:  K H Lu; J Meites
Journal:  Endocrinology       Date:  1973-07       Impact factor: 4.736

5.  Inhibition of rat prolactin release by apomorphine in vivo and in vitro.

Authors:  E B Smalstig; B D Sawyer; J A Clemens
Journal:  Endocrinology       Date:  1974-07       Impact factor: 4.736

6.  [Clinical and electroencephalographic effects of methoclopramide in psychiatry].

Authors:  P Borenstein; G Bles
Journal:  Therapie       Date:  1965 Jul-Aug       Impact factor: 2.070

7.  Loxapine: a controlled evaluation in chronic schizophrenic patients.

Authors:  M P Bishop; D M Gallant
Journal:  Curr Ther Res Clin Exp       Date:  1970-09

8.  Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity.

Authors:  H M Van Praag; J Korf; L C Dols
Journal:  Br J Psychiatry       Date:  1976-12       Impact factor: 9.319

9.  6-(4-Methyl-1-piperazinyl)morphanthridine (Perlapine), a new tricyclic compound with sedative and sleep-promoting properties. A pharmacological study.

Authors:  G Stille; A Sayers; H Lauener; E Eichenberger
Journal:  Psychopharmacologia       Date:  1973-02-20

10.  Effect of metabolites of chlorpromazine on plasma prolactin levels in male rats.

Authors:  H Y Meltzer; V S Fang; M Simonovich; S M Paul
Journal:  Eur J Pharmacol       Date:  1977-02-21       Impact factor: 4.432

View more
  1 in total

1.  Atypical antidopaminergic properties of CI-686: a potential antipsychotic agent.

Authors:  M Stanley; J Rotrosen; N Sculerati; S Gershon; C Kuhn; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.